Geneticure

geneticure.com

Geneticure is a Mayo Clinic-backed company that has developed a patented DNA test to personalize hypertension treatment. By analyzing 17 genotypes and 11 genes, the test provides tailored medication recommendations, significantly reducing trial-and-error in treatment. The company leverages a unique multi-gene algorithm to optimize blood pressure management, demonstrating a 22% reduction in systolic and 39% in diastolic pressure compared to standard care. With a strong foundation in pharmacogenomics and a team of experts, Geneticure is positioned to lead in personalized medicine for hypertension, aiming to improve patient outcomes and reduce healthcare costs.

Is this your company?